Seegene's product news
Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ Meningitis Panel-V1, Allplex™ Meningitis-V2 Assay, Allplex™ Meningitis-B Assay.
These assays are the multiplex one-step Real-time RT-PCR assay that detect and identifie 18 meningitis causative pathogens including 12 viruses and 6 bacteria. Based on Seegene’s proprietary MuDT™ technology, it allows reporting of each Ct value for multiple pathogens in a single channel without the melt curve analysis.
|Previous||Obtained approval of MFDS for Allplex™ GI- Bacteria(I) Assay||2017.05.26|
|Next||Obtained CE-IVD marking for Allplex™ GI-Virus plus Assay||2019.01.22|